Modern Family Star Eric Stonestreet and His Mom, a Two Time Cancer Survivor, Join Forces to Raise Awareness of Immuno-Oncology Research through Ready. Raise. Rise. Campaign

  • Ready. Raise. Rise. creates a social movement to honor
    cancer patients and caregivers and helps provide charitable donations
    to advocacy organizations
  • Bristol-Myers Squibb and Eric Stonestreet call on anyone touched by
    cancer to raise and share a virtual flag to support the cancer
    community

NEW YORK–(BUSINESS WIRE)–$BMY #CancerImmunotherapyMonth–The Ready. Raise. Rise. campaign encourages everyone to
raise and share a flag to salute those who have been touched by cancer,
especially patients and caregivers, and learn more about a rapidly
evolving area of research, Immuno-Oncology, which seeks to harness the
body’s own immune system to fight cancer. For the campaign’s
second year, Eric Stonestreet of television’s hit comedy “Modern Family”
and films “Confirmation” and “The Secret Life of Pets” is joined by his
mother Jamey, who faced and survived cancer twice. Bristol-Myers Squibb
sponsors the campaign, which inspired people to raise more than 50,000
flags last year, and this year will make charitable donations to 23
participating cancer support groups on behalf of flag raisers.


This press release has an accompanying Smart Marketing Page providing
further details about the organization, products and services introduced
below. You can access the Smart Marketing Page via the following link: http://smp.newshq.businesswire.com/pages/modern-family-star-eric-stonestreet-and-his-mom-two-time-cancer-survivor-join-forces-raise-awa.

“My mom has survived cancer twice, so I have personal reasons for
standing with Ready. Raise. Rise. again this year – It
gives me a chance to say how much I admire heroes like her, and at the
same time it allows me to learn about promising research in the fight
against cancer, like Immuno-Oncology. And participating in the campaign
also supports cancer advocacy groups that are helping others like my
mom,” said Eric Stonestreet. “So mom and I are asking you to be Ready to
Raise a virtual flag and Rise in celebration of patients, caregivers and
anyone else you know whose life is touched by cancer.”

With more than 32 million people living with cancer worldwide, nearly
every family is impacted by cancer. Stonestreet is asking people to go
to ReadyRaiseRise.com to
create and share a flag in honor of someone who has been affected by
cancer – whether it be themselves, a loved one or a caregiver. Each
person who raises a flag can select one of 23 cancer advocacy
organizations they wish to support and share their flag on social media
using the hashtag #RaiseYourFlag. For each flag raised and shared, the
selected organization will receive a charitable donation from
Bristol-Myers Squibb. The company will distribute up to a total of
$150,000 in charitable donations across participating organizations.
Both Stonestreet and his mother are featured in a public service
announcement to further extend the reach of the educational information
about Immuno-Oncology research.

“Immuno-Oncology is an innovative area of research that may be changing
the way we approach cancer,” said Sanjiv Agarwala, MD, chief of medical
oncology and hematology at St. Luke’s Cancer Center in Bethlehem, PA,
and professor of medicine at Temple University School of Medicine in
Philadelphia, PA. “I’m passionate about educating the cancer community
about Immuno-Oncology research as it explores a different way to
approach cancer treatment, and that may allow patients with advanced
cancer the potential to lead longer lives.”

Ready. Raise. Rise. continues to resonate with the cancer
community, further motivating us to relentlessly pursue Immuno-Oncology
research and make a difference for patients,” said Teresa Bitetti,
senior vice president, U.S. Oncology, Bristol-Myers Squibb. “Our
ultimate goal with Immuno-Oncology is to improve survival and quality of
life for patients living with various types of cancer, and this program
provides an inspiring platform to honor patients and caregivers in a
meaningful way.”

Immuno-Oncology at Bristol-Myers Squibb

Bristol-Myers Squibb is leading research in an innovative field of
cancer research and treatment known as Immuno-Oncology, which involves
agents whose primary mechanism is to work directly with the body’s
immune system to fight cancer. The company is exploring a variety of
compounds and immunotherapeutic approaches for patients with different
types of cancer, including researching the potential of combining
Immuno-Oncology agents that target different pathways in the treatment
of cancer.

Bristol-Myers Squibb is committed to advancing the science of
Immuno-Oncology, with the goal of changing survival expectations and the
way patients live with cancer.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedInTwitter,
YouTube
and Facebook.

Contacts

Media:
Bristol-Myers Squibb
Laurel Sacks, 609-897-2944
Laurel.sacks@bms.com
or
Carrie
Fernandez, 609-897-4957
Carrie.fernandez@bms.com
or
Christine
Hanson, 917-634-0608
Christine.ennishanson@ogilvy.com